Purchase Order 75N91022P00508
- Not listed
- This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $95,509.00, is for the procurement of one (1) I-DOT 2.0 dispensing system for the preparation of next-generation sequencing (NGS) library preps of T-cell receptors (TCRs) in support of cancer research. The contract was set aside for small businesses, and the prime...
- The Department of Health and Human Services National Institutes of Health National Institute on Deafness and Other Communication Disorders awarded a firm-fixed-price purchase order contract to Cellink LLC, a foreign-owned, for-profit company, for an annual service contract for a laboratory instrument. The contract, which does not have a set-aside designation, has a potential value of $16,073.00 and a completion date of March 19, 2025. Cellink LLC, which is based in Washington, D.C., provides...
- This $24,650 firm fixed price purchase order contract was awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) to Cellink LLC, a foreign-owned for-profit biotech company, to provide a 1-year annual service plan for their F.Sight robotic cell printing platform. The contract has a completion date of June 9, 2025, and was awarded on June 10, 2024 without the use of a small business set-aside. Cellink, headquartered in Germany, is a leading provider of...
- This is a firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders, a civilian federal agency, to Cellink LLC, a foreign-owned for-profit biotech company. The $24,999.00 contract is for a "PREMIUM CUSTOMER CARE PACKAGE F.SIGHT/F.SIGHT 2.0 - 1 YEAR" from August 15, 2025 to June 14, 2026. Cellink is a leading provider of advanced biomedical research equipment such as 3D bioprinters and liquid handling systems, and has secured...
- The Department of Health and Human Services' National Institutes of Health National Institute of Dental and Craniofacial Research awarded a $136,898.19 firm-fixed-price purchase order to Cellink LLC, a foreign-owned for-profit organization, to provide a non-contact, low-volume dispensing system (I-DOT) to be performed in Blacksburg, Virginia. Cellink has previously provided 3D bioprinters, liquid handling systems, and related products and services to various federal agencies including the NIH,...
- This federal contract award is to CELLINK LLC, a foreign-owned, for-profit organization that specializes in bioconvergence technologies. The contract, valued at $78,530.00, is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. CELLINK LLC is a leading provider of 3D bioprinters, liquid handling systems, and...
- This federal contract award is for the acquisition of an automatic cell culture station, including a liquid handler, thermoplate, incubator, and live cell imager, by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract was awarded to Cellink LLC, a foreign-owned, for-profit organization, on a firm-fixed price basis for a potential value of $151,928.00. The...
- This is a $96,978.00 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Cellink LLC, a foreign-owned for-profit biotech company. The contract was awarded under a small business set-aside and provides for the delivery of two 3D bioprinters capable of generating 3D constructs with pluripotent stem cells and their differentiated counterparts. The bioprinters are to include...
- The Department of the Navy Secretary of the Navy Office of Naval Research awarded a firm fixed-price purchase order contract to Cellink LLC, a foreign-owned for-profit organization, to provide a Microbial Single Cell Isolation System. The contract has a potential value of $206,639.00 and a completion date of October 11, 2023. Cellink LLC is an established federal government vendor that has previously provided bioprinters, robotic liquid handling systems, 3D cell culture systems, and related...
- This firm fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Cellink LLC, a foreign-owned for-profit biotech company based in Germany. The $85,489.00 contract is for the procurement of a BIONOVA X 3D bioprinter and associated software, bioink, warranty, and installation/training services. This requirement was a streamlined solicitation for commercial items with...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Cellink LLC for preventive maintenance, emergency service, support, and coverage for a government-owned Cellink I-DOT One dispensing system (S/N: I2-211089). The contract has a total ceiling value of $62,464.50 and a period of performance from June 1, 2022 to June 2, 2025, with no set-aside designation. Cellink LLC, a foreign-owned, for-profit biotech company specializing in advanced bioconvergence technologies, was selected as the sole provider of these services due to the proprietary and specialized nature of the I-DOT One system, which is critical to the NCI's single-cell sequencing research efforts. The contract includes preventive maintenance, emergency repair services, software updates, and technical support.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Preventive Maintenance, Emergency Service, Support, and Coverage for a Government-Owned I-DOT One Dispensing System (S/N: I2-211089) | 75N91022Q00069 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Pre-Solicitation 1/1 | 4/22/22, 3:44 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Terminate for Convenience | $0 | 6/2/25 | |
| P00002 | Exercise an Option | $12.5k | 5/30/24 | |
| P00001 | Exercise an Option | $12.5k | 5/11/23 | |
| Not listed | Not listed | $12.5k | 5/20/22 |